Characteristic | B | Hazard ratio (95% CI) | P |
---|---|---|---|
Progression-free survival | |||
ECS | 0.602 | 1.826(1.223–2.727) | 0.003 |
Overall survival | |||
ECS | 1.333 | 3.793(2.016–7.136) | < 0.001 |
Status of lymph node | 0.900 | 3.293(1.794–6.044) | < 0.001 |
Loco-regional relapse-free survival | |||
ECS | 0.565 | 1.760(1.113–2.784) | 0.016 |
Distant metastasis-free survival | |||
Type of treatment | -0.413 | 0.662(0.465–0.941) | 0.021 |
ECS | 0.603 | 1.827(1.010–3.305) | 0.046 |